Supernus Pharmaceuticals | Spese Operative



Operating Expenses Cambiamento Data
Abbott USD 8.7B 363M 2025-03
ANI Pharmaceuticals USD 170.93M 24.02M 2025-03
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 153.8M 2.83M 2025-03
Eisai JPY 189.26B 684M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Indivior 200M 193M 2025-03
Novo Nordisk 39.3B 1.81B 2025-03
Pacira USD 166.93M 4.38M 2025-03
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
United Therapeutics USD 411.6M 33.4M 2025-03
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12



Supernus Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.